Congress Resources
Publications
Molecules
Clinical Trials
Hematology Solid Tumors
Disease Education
Hematology Solid Tumors
Pipeline
Login

HOME>DISEASE EDUCATION>SOLID TUMORS>BEGENIUS>SPOTLIGHT SERIES

BeGenius Spotlight Series

Learn about the latest developments in lung cancer.

All educational content is sponsored by BeOne Medicines.

RATIONALE-312: Long-term follow-up in ES-SCLC

18 May 2026

Efficacy of PD-(L)1 inhibitors for NSCLC in Asian vs. non-Asian populations

18 May 2026

What to do in NSCLC with low PD-L1 expression?

29 Apr 2025

RATIONALE-307: Tislelizumab as 1L treatment for advanced squamous NSCLC

29 Apr 2025

RATIONALE-315: Perioperative tislelizumab in 1L resectable NSCLC

24 Jul 2025

RATIONALE-312: Tislelizumab + chemotherapy in 1L ES-SCLC

29 Oct 2025

RATIONALE-304: Tislelizumab in 1L advanced non-squamous NSCLC

24 Nov 2025

RATIONALE-315 final analysis: Perioperative tislelizumab in 1L resectable NSCLC

19 Dec 2025

Report an Adverse Event

adverse_events@beonemed.com

Report a Product Complaint

productcomplaints@beonemed.com

Contact us

beonemedicines.com/contact-us/

This website is intended for Healthcare Professionals for scientific information exchange purposes only, not for advertising purposes, and does not constitute commercial promotion of any product or recommendation on diagnosis and treatments. The website may contain information about products or indications that have not yet been approved in your country; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions. The safety and efficacy of investigational products or uses may not have been established. Because of the uncertainty of clinical trials, there is no guarantee that compounds will receive regulatory approval and become commercially available for the uses being investigated.

Congress Resources Publications Molecules

My Account Pipeline

External Links

Find a Clinical Trial

Investigator-Initiated Trial (IIT) Portal

Research & Development

Terms of Use
Privacy Policy
Cookie Preferences

© BeOne Medicines I GmbH 2026.

Welcome to BeOne Medical

Are you a returning user?

For new users, please select your country/region

This website is intended exclusively for healthcare professionals and is provided for scientific exchange and educational purposes only. It is not intended for patients or the general public and does not constitute advertising, promotional activity or medical advice.

Content may include information about products, indications or uses that are not approved in all countries or regions, and may be subject to local regulatory requirements.

By continuing, you confirm that you are a healthcare professional and acknowledge the above.

You are now leaving the website

This link is provided for information purposes only. You’ll be leaving beonemedaffairs.com and accessing a third-party website over which [BeOne Medicines | GmbH] has no control or influence.

This link will take you to a third-party website outside of beonemedaffairs.com.

[BeOne Medicines | GmbH] has no control over this website and makes no representations regarding its content or availability in your location. [BeOne Medicines | GmbH] declines any responsibility for third-party information, data usage policies, or personal data processing.

By proceeding, you acknowledge that you are part of the intended audience of the third-party website and confirm your compliance with applicable laws.

Do you want to leave beonemedaffairs.com

You are now leaving the the website beonemedaffairs.com and entering another BeOne website with different terms of use. Information included on this website may not be specific to your country. Click Continue to proceed